Lung cancer screening: Is it time for a change in policy?

Article Type
Changed
Wed, 07/18/2018 - 10:57
Display Headline
Lung cancer screening: Is it time for a change in policy?
Article PDF
Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Issue
Cleveland Clinic Journal of Medicine - 74(6)
Publications
Topics
Page Number
441-448
Sections
Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Author and Disclosure Information

Peter Mazzone, MD, MPH
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Moulay Meziane, MD
Head, Section of Chest Radiology, Department of Diagnostic Radiology and Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Nancy Obuchowski, PhD
Department of Diagnostic Radiology and Department of Quanititative Health Sciences, Cleveland Clinic

Muzaffar Ahmad, MD
Department of Pulmonary, Allergy, and Critical Care Medicine, Cleveland Clinic

Tarek Mekhail, MD, MS
Department of Solid Tumor Oncology, Cleveland Clinic

Address: Peter Mazzone, MD, Department of Pulmonary, Allergy, and Clinical Care Medicine, A90, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail: [email protected]

Dr. Mekhail has indicated that he is on the speaker’s bureaus of the Genentech, Sanofi-Aventis, and Eli Lilly corporations.

Article PDF
Article PDF
Related Articles
Issue
Cleveland Clinic Journal of Medicine - 74(6)
Issue
Cleveland Clinic Journal of Medicine - 74(6)
Page Number
441-448
Page Number
441-448
Publications
Publications
Topics
Article Type
Display Headline
Lung cancer screening: Is it time for a change in policy?
Display Headline
Lung cancer screening: Is it time for a change in policy?
Sections
PURLs Copyright

Disallow All Ads
Alternative CME
Use ProPublica
Article PDF Media